Invention Grant
US09198912B2 Schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (HIV) 有权
用于治疗患有人体免疫机能丧失病毒(HIV)的人的组合疗法的时间表

Schedules for administering combination therapies useful for treating persons afflicted with the human immunodeficiency virus (HIV)
Abstract:
The invention relates to a pharmaceutical composition for treating the human immunodeficiency virus (HIV) in humans, including three or four active principles selected as: a nucleoside reverse transcriptase inhibitor (NARTI) selected from lamivudine and emtricitabine; a nucleoside or nucleotide reverse transcriptase inhibitor (NARTI) selected from didanosine, abacavir and tenofovir; and the combination of ritonavir with a protease inhibitor (PI) selected from lopinavir, fosamprenavir, atazanavir and darunavir; or an non-nucleoside reverse transcriptase inhibitor (NNRTI) selected from efavirenz and etravirine; for daily administration to said human being one to four days per week.
Information query
Patent Agency Ranking
0/0